The U.S. Court of Appeals for the Ninth Circuit on Wednesday affirmed a district court’s decision to grant a temporary ...
Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read more on ACAD stock here.
The US Court of Appeals for the Federal Circuit affirmed attorneys’ fees awards against EscapeX IP, LLC, finding the case “exceptional” under ...
Below, CNBC Select explains the differences between trademarks, copyrights and patents. Read on for more information and to ...
Zacks Investment Research on MSN
Can Merck's new products aid growth as Keytruda LOE test looms?
Merck MRK is going to face a major patent cliff, as its blockbuster PD-L1 therapy Keytruda is nearing loss of exclusivity ...
Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug ...
ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, tod ...
Council and Parliament reach provisional deal on a set of rules for new genomic techniques, aiming to improve the ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the ...
The Delhi High Court on Tuesday dismissed Novo Nordisk's application to restrain Dr. Reddy's Laboratories Limited and ...
Introduction - Far too often, startup founders treat intellectual property (IP)—especially patents—like an item on a to-do list.
The U.S. International Trade Commission (ITC) found the violation of one patent owned by Infineon Technologies AG (FSE: IFX) (OTCQX: IFNNY) concerning gallium nitride (GaN) technology by Innoscience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback